Analysis of micronucleus induction of pyrimethamine in in vitro CHL cells and in in vivo mouse bone marrow cells

Mutagenesis

Volumn 11, Issue 1, 1996, Pages 85-88

  Ono, Tomoko ^a   Yoshimura, Haruo ^a  

^a NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; PYRIMETHAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LUNG; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; BONE MARROW; CELL LINE; CRICETINAE; CRICETULUS; LUNG; MALE; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENS; PYRIMETHAMINE;

EID: 0030034271     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/11.1.85     Document Type: Article

References (26)

1. Adler,I.-D., Kliesch,U., van Hummelen,P. and Kirsch-Volders,M. (1991) Mouse micronucleus test with known and suspect spindle poisons: results from two laboratories. Mutagenesis, 6, 47-53.
2. Antoccia,A., Degrassi,F. Battistoni,A., Ciliutti,P. and Tanzarella,C. (1991) In vitro micronucleus test with kinetochore staining: evaluation of test performance. Mutagenesis, 6, 319-324.
3. Bonatti,S., Cavalieri,Z., Viaggi,S. and Abbondandolo,A. (1992) The analysis of 10 potential spindle poisons for their ability to induce CREST-positive micronuclei in human diploid fibroblasts. Mutagenesis. 7, 111-113.
4. Cavallito,J.C., Nichol,C A., Brenckman,W.D., Deangelis,R.L., Jr, Stickney,D R., Simmons,W S. and Sigel, C.W. (1978) Liquid-soluble inhibitors of dihydrofolate reductase I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man. Drug Metab. Disp., 6, 329-337.
5. CSGMT (Collaborative Study Group for the Micronucleus Test) (1990) Single versus multiple dosing in the micronucleus test: the summary of the fourth collaborative study by CSGMT/JEMS MMS. Mutat. Res., 234, 205-222.
6. CSGMT (Collaborative Study Group for the Micronucleus Test) (1992) Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: the summary report of the 5th collaborative study by CSGMT/JEMS.MMS. Mutat. Res.. 278, 83-98.
7. Egeli,U. and Erdogan,G. (1991) The clastogenic effect of pyrimethamine (Daraprim) on human chromosomes in lymphocyte cultures. Cell Biol. Toxicol., 7, 347-356.
8. Everson,R.B. Wehr,C.M., Erexson,G L., and MacGregor,J.T. (1988) Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. J. Natl. Cancer Inst., 80, 525-529
9. Eyles,D.E. and Coleman,N. (1953) Synergistic effect of sulfadiazine and Daraprim against experimental toxoplasmosis in the mouse. Antibiot. Chemother., 3, 483-490.
10. Eyles,D.E. and Coleman,N. (1955) An evaluation of the curative effects of pyrimethamine and sulfadiazine. alone and in combination, on experimental mouse Toxoplasmosis Antibiol. Chemother., 5, 529-539.
11. Ferone,R., Burchall,J.J. and Hitchings,G.H. (1969) Plasmodium bergher dihydrofolate reductase isolation, properties, and inhibition by antifolates. Mol Pharmacol., 5, 49-59
12. Hayashi,M., Morita,T., Kodama,Y., Sofuni,T. and Ishidate,M., Jr. (1990) The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res., 245, 245-249.
13. Karbwang,J., Back,D.J., Bunnag,D. and Breckenridge,A.M. (1990) Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria. Bull WHO, 68, 633-638.
14. Kasahara,Y., Nakai,Y, Miura,D., Yagi,K., Hirabayashi,K. and Makjta,T. (1992) Mechanism of induction of micronuclei and chromosome aberrations in mouse bone marrow by multiple treatments of methotrexate. Mutat. Res., 280, 117-128.
15. Kastenbaum,M.A. and Bowman,K.O. (1970) Tables for determining the statistical significance of mutation frequencies. Mutat. Res., 9, 527-549.
16. Kendall,S.B. (1956) Synergy between pyrimethamine and sulphonamides used in the control of Eimeria tenella. Proc. Roy. Cos. Med., 49, 874-877.
17. Kondo,Y, Honda,S., Nakajima,M., Miyahara,K., Hayashi,M., Shinagawa,Y., Sato,S., Inoue,K., Nito,S. and Ariyuki,F. (1992) Micronucleus test with vincristine sulfate and colchicine in peripheral blood reticulocytes of mice using acridine orange supravital staining. Mutat. Res., 278, 187-191.
18. Koyama,H., Utakoji,T. and Ono,T. (1970) A new cell line derived from newborn Chinese hamster lung tissue. Gann, 61, 161-167.
19. MacGregor,J.T., Wehr,C.M. and Gould,D.H. (1980) Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. Environ. Mutagen., 2, 509-514.
20. Matsuoka,A., Yamazaki,N., Suzuki,T., Hayashi,M. and Sofuni,T. (1993) Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res., 272, 223-236.
21. Ono,T., Norimatsu,M. and Yoshimura,H. (1994) Induction of chromosome aberrations by pyrimethamine in cultured Chinese hamster (CHL) cells. Mutat. Res., 323, 197-201.
22. Pearlman,E.J., Lampe,R.M., Thiemanun,W. and Kennedy,R.S. (1977) Chemosuppressive field trials in Thailand III. the suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by a sulfadoxine-pyrimethamine combination. Amer. J. Trop. Med. Hyg., 26, 1108-1115.
23. Satoh,K., Kojima,N., Furuno,M., Kokue,E. and Hayama,T. (1991) Ameliorative effect of folic acid on pyrimethamine teratogenesis in pigs. Cong. Anom., 31, 323-328.
24. Sheffield,H.G. and Melton,M.L. (1975) Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures. J. Parasitol., 61, 704-712.
25. Tsunematsu,K., Shimoda,M. and Hayama,T. (1992) Effect of folic acid on pharmacokinetics of pyrimethamine in rats. Cong. Anom., 32, 357-365.
26. Yamamoto,K.I. and Kikuchi,Y. (1980) A comparison of diameters of micronuclei induced by clastogens and by spindle poisons. Mutat. Res., 71, 127-131.